Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

This study has been completed.
Sponsor:
Collaborators:
Alberta Heritage Foundation for Medical Research
Royal Alexandra Hospital
Information provided by:
University of Alberta
ClinicalTrials.gov Identifier:
NCT00175175
First received: September 9, 2005
Last updated: September 13, 2006
Last verified: September 2006

September 9, 2005
September 13, 2006
March 2002
Not Provided
The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture
Same as current
Complete list of historical versions of study NCT00175175 on ClinicalTrials.gov Archive Site
  • Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
  • Proportion in receipt of a BMD test at 6 months and 12 months
  • Proportion still adherent to osteoporosis treatments at 6 months and 12 months
  • Proportion of patients with recurrent fractures at 6 months and 12 months
  • Cost effectiveness analyses
  • 1. Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
  • 2. Proportion in receipt of a BMD test at 6 months and 12 months
  • 3. Proportion still adherent to osteoporosis treatments at 6 months and 12 months
  • 4. Proportion of patients with recurrent fractures at 6 months and 12 months
  • 5. Cost effectiveness analyses
Not Provided
Not Provided
 
Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients
Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
  • Osteoporosis
  • Hip Fracture
Behavioral: Allied health professional-run osteoporosis service ("case-management")
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
220
Not Provided
Not Provided

Inclusion Criteria:

  • hip fracture patient > 50 years of age
  • able to give consent (or proxy consent available)
  • lives within health region
  • no contraindications to bisphosphonate therapy

Exclusion Criteria:

  • refuses to participate or consent
  • dementia or delirium without a proxy consent available
  • nursing home or longterm care
  • pathologic fracture
  • chronic glucocorticoid use
  • already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)
Both
50 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00175175
AHFMR #200100791
Not Provided
Not Provided
University of Alberta
  • Alberta Heritage Foundation for Medical Research
  • Royal Alexandra Hospital
Principal Investigator: Sumit R Majumdar, MD, MPH University of Alberta
University of Alberta
September 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP